News

31/03/2021

Sant Pau develops and administers the first CAR-T of its own production for Hodgkin and non-Hodgkin lymphoma T in Europe

The first CAR-T immunotherapy drug produced entirely in Sant Pau and administered to the first patient, is part of a clinical trial of the centre itself, pioneer in Europe, of phase I CAR-T immunother...

16/03/2021

Foment and Activa’tt per la Salut will collaborate in a campaing for the prevention of vascular diseases

Thanks to this agreement, a mobile vascular disease assessment service will be promoted. Also, companies will be able to collaborate and help fund research into the fight against vascular diseases. ...

04/03/2021

Sant Pau inaugurates a new Phase I clinical trials Unit in onco-haematology

This new unit makes it possible to coordinate and carry out complex clinical trials with drugs in the early development phase, thus studying and offering new treatment opportunities for cancer patient...

19/02/2021

Solidarity Art Exhibition

The Sant Pau Art Nouveau Site hosts the "Solidarity Art" Exhibition, from February 26th to March 26th, to benefit the research on Covid-19. We will find works by Silvio Alino, Art is Trash, Carles Azc...

19/02/2021

Molecular Mechanism that Causes a Severe Cardiac Arrhythmia Identified

  A multidisciplinary team of researchers from the University of Calgary, the Sant Pau Research Institute (IIB Sant Pau) and the Institute of Biomedical Research of Barcelona (IIBB-CSIC), and ...